Compliance · State rules

Office-use compounding in Utah

Permitted by statute, conditioned on federal law by the implementing rule

USPeptideRx EditorialLast reviewed: August 30, 2026

Utah has a statute titled for this exact transaction — sale of a prescription drug to a practitioner for office use — and it is one of the cleanest office-use grants in this file, with four conditions and its own mandatory legend. But the statute grants the permission "subject to rules established by the division", and the division’s entire implementing rule is a single sentence re-granting it on condition of compliance with all applicable federal law, naming the federal Food, Drug, and Cosmetic Act. So Utah is a permission with a federal condition written into the rule rather than the statute. One more thing sits inside the grant and almost nobody draws it: Utah permits repackaged manufactured controlled substances for office use and excludes COMPOUNDED controlled substances by name.

The governing rule

Utah’s office-use position is set by Utah Code § 58-17b-624; Utah Admin. Code R156-17b-624. The text below is quoted verbatim; everything outside a quote block is our summary of it, and the two are kept visually separate on purpose.

Utah Code § 58-17b-624(1) — the grant, and note the six words that subordinate it

A pharmacy licensed under this chapter may, subject to rules established by the division, repackage or compound a prescription drug for sale to a practitioner if:

Utah Code § 58-17b-624(1)(a) — the drug-class exclusion, inside the grant itself

(i) does not include a compounded drug; or (ii) (A) includes a compounded drug; and (B) is not a controlled substance;

Utah Code § 58-17b-624(1)(b) — the mandatory legend

the pharmacy labels the prescription drug "for office use only"

Utah Admin. Code R156-17b-624 — the entire rule, quoted whole because it is one sentence

Pursuant to Section 58-17b-624, a pharmacy may repackage or compound a prescription drug for sale to a practitioner for office use provided that it is in compliance with all applicable federal and state laws and regulations regarding the practice of pharmacy, including, but not limited to the Food, Drug, and Cosmetic Act, 21 U.S.C.A 301 et seq.

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

Two instruments, two different characters — and both must be publishedMedium confidence: The statute contains no federal hook at all; read alone it would be a plain state grant of the kind Kansas and Nebraska wrote. The implementing rule is one sentence, and that sentence is a federal-compliance condition. This page treats the rule as controlling, because the statute expressly subordinates itself to "rules established by the division". A court could instead read the rule as merely declaratory of the general compliance duty that already sits at § 58-17b-618, in which case Utah is a clean state permission and belongs beside Kansas and Nebraska.Both readings are published deliberately, because which instrument controls decides what kind of state Utah is and nothing we found settles it. The construction that is safe either way: Utah’s statute expressly authorises office-use sales, the implementing rule conditions that authority on compliance with the federal act, and state permission does not create a federal exemption in any event.
The drug-class exclusion, which is the sharpest thing on this pageHigh confidence: The grant reaches a drug that either does not include a compounded drug at all, or includes one and is not a controlled substance. Read plainly: a repackaged manufactured controlled substance may go to a practitioner for office use, and a COMPOUNDED controlled substance may not. The line falls between compounded and manufactured within the same schedule, which is not where anyone expects it.This is the clearest instance in the file of a permission that is not uniform across drug classes. A page that states Utah’s permission without it has published half the rule, and the half it dropped is the half a controlled-substance order turns on.
The rest of the conditionsHigh confidence: The drug must be labelled "for office use only"; it must be administered by the practitioner; and it must not be dispensed. The legend is mandatory and is written into the statute rather than into a rule.
Quantity and sterilityHigh confidence: Neither instrument states a numeric cap, and neither draws a sterile or non-sterile distinction. What limits the transaction in Utah is the drug-class exclusion and the federal condition, not a volume.
A live citation-rot problem inside Utah’s own rulesHigh confidence: Utah renumbered its entire Controlled Substances Act with effect from 1 July 2026, and no section of the old numbering survives — the licensing section moved from § 58-37-6 to § 58-37-105. The division’s own controlled-substances rule still cites the dead section eighteen times, including in its authority line. Any Utah controlled-substance citation older than that date needs re-checking before it is relied on.
Two dated fuses on the rules this page depends onHigh confidence: Utah rules expire automatically unless the division files to continue them. The general division rule is due to lapse on 2 November 2026 and the controlled-substances rule on 15 December 2026 unless continued. Neither is the office-use rule itself, which was last amended on 8 August 2025 and survived that amendment untouched — but both sit underneath the licensing framework this page describes.

Utah at a glance

Utah office-use compounding summary, reviewed 2026-08-30
Human office use	Permitted by statute, conditioned on federal law by rule
Sterile preparations	No split in either instrument
Quantity cap	None numeric
Mandatory label legend	Yes — "for office use only", in the statute
Board reporting	None for office use
Last change	Office-use rule last amended August 2025, unchanged
Governing rule	Utah Code § 58-17b-624; Utah Admin. Code R156-17b-624

Receiving 503B office stock in Utah

Utah has no outsourcing-facility category at all — the term does not appear anywhere in Utah law — and the credential does not come from a board of pharmacy. The Division of Professional Licensing issues it; the Board is advisory and recommends only.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Utah asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence: A pharmacy licence in the appropriate class: Class C for an in-state manufacturer or wholesaler, Class D for a nonresident. There is no outsourcing facility category in Utah law — verified several ways, including against the legislature’s own full-text index, where the term appears once in an unrelated consumer-notice statute.The issuing body is the Division of Professional Licensing inside the Department of Commerce, not a board: § 58-17b-302(2) says the division shall issue a pharmacy licence, and § 58-1-202(1) confines the Board to recommending. Routing a Utah drug credential to a "board of pharmacy" sends the reader somewhere that cannot issue it.
Does your practice need a permit?Medium confidence: The office-use statute is written around the practitioner receiving and administering the drug, and imposes its conditions on the pharmacy rather than on the practice. This page does not establish a separate Utah facility credential for a receiving practice.
Administer vs dispenseHigh confidence: The statute draws the line itself and does so twice: the drug must be administered by the practitioner, and it must not be dispensed. Those are conditions of the grant, so a practice that hands the product to a patient is outside the permission rather than merely in breach of a labelling duty.
Scheduled (controlled) stockMedium confidence: Utah issues a state controlled-substance licence through the same division. Note the interaction with the grant: compounded controlled substances are excluded from the office-use permission by name, so for that class the licensing question does not arise on this route at all. And every controlled-substance citation predating 1 July 2026 needs re-checking against the renumbered Act.

How to check a facility’s credential before you order is set out in how to place an office-use order.

The federal layer still applies

Whatever Utah law allows, federal law applies on top of it and is not satisfied by state permission. 21 U.S.C. § 353a conditions the federal compounding exemptions on a drug being compounded for an identified individual patient on receipt of a valid prescription order. A state rule cannot create a federal safe harbour, and several state rules say so in their own text. The separate federal pathway for non-patient-specific office stock is the 503B outsourcing facility — the differences are set out in 503A vs 503B.

For how Utah compares with the other states reviewed, see the state-by-state comparison.

What this page does not establish

Which instrument controls — the statute or its one-sentence implementing rule — is the question that decides whether Utah is a clean permission state or a conditioned one, and nothing we found settles it. A division declaratory order, a guidance document, or any Utah case construing "subject to rules established by the division" would resolve it. Both readings are published above for that reason.
Two of the rules underneath this page’s licensing framework are due to lapse automatically unless the division files to continue them, in November and December 2026. We cannot tell you whether those filings will be made.
The Controlled Substances Act renumbering of 1 July 2026 has left the division’s own rule citing a repealed section eighteen times. That is the state’s citation problem rather than ours, but it means any Utah controlled-substance reference you encounter — including in official material — may point at a section that no longer exists.
We searched no case law, attorney-general opinions, board newsletters or disciplinary orders for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.

Sources

Primary sources, fetched directly from the issuing body. No secondary summaries.